Quantifying the role of naturally- and vaccine-derived neutralizing antibodies as a correlate of protection against COVID-19 variants
Open Access
- 1 June 2021
- preprint content
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
The functional relationship between neutralizing antibodies (NAbs) and protection against SARS-CoV-2 infection and disease remains unclear. We jointly estimated protection against infection and disease progression following natural infection and vaccination from meta-study data. We find that NAbs are strongly correlated with prevention of infection and that any history of NAbs will stimulate immune memory to moderate disease progression. We also find that natural infection provides stronger protection than vaccination for the same level of NAbs, noting that infection itself, unlike vaccination, carries risk of morbidity and mortality, and that our most potent vaccines induce much higher NAb levels than natural infection. These results suggest that while sterilizing immunity may decay, we expect protection against severe disease to be robust over time and in the face of immune-evading variants.Keywords
This publication has 23 references indexed in Scilit:
- Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and VaccinationJAMA, 2021
- Neutralizing Activity of BNT162b2-Elicited SerumThe New England Journal of Medicine, 2021
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in EnglandScience, 2021
- Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational studyThe Lancet, 2021
- Serological reconstruction of COVID-19 epidemics through analysis of antibody kinetics to SARS-CoV-2 proteinsPublished by Cold Spring Harbor Laboratory ,2021
- Negligible impact of SARS-CoV-2 variants on CD4+and CD8+T cell reactivity in COVID-19 exposed donors and vaccineesPublished by Cold Spring Harbor Laboratory ,2021
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionScience, 2021
- Correlates of protection against SARS-CoV-2 in rhesus macaquesNature, 2020
- Robust neutralizing antibodies to SARS-CoV-2 infection persist for monthsScience, 2020
- Role of modelling in COVID-19 policy developmentPaediatric Respiratory Reviews, 2020